Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 151 - 200 av 212 resultater
Tid
Selskap
Tittel
Sektor
Kategori
28 Mar 2022
18:00 CEST
ADOCIA
ADOCIA Strengthens Its Cash Position by 19 Million Euros Following a Real Estate Transaction
20103010 Biotechnology
Other subject
28 Mar 2022
18:00 CEST
ADOCIA
ADOCIA renforce sa trésorerie de 19 millions d’euros à la suite d’une opération immobilière
20103010 Biotechnology
Other subject
16 Mar 2022
18:00 CET
ADOCIA
Number of Shares and Voting Rights of Adocia as of February 28th, 2022
20103010 Biotechnology
Other subject
16 Mar 2022
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 28 février 2022
20103010 Biotechnology
Other subject
23 Feb 2022
18:00 CET
ADOCIA
ADOCIA communique ses résultats financiers du 4ème trimestre 2021
20103010 Biotechnology
Other subject
23 Feb 2022
18:00 CET
ADOCIA
ADOCIA Announces 2021 Fourth Quarter Financial Results
20103010 Biotechnology
Other subject
15 Feb 2022
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 janvier 2022
20103010 Biotechnology
Other subject
15 Feb 2022
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of January 31st, 2021
20103010 Biotechnology
Other subject
13 Jan 2022
18:00 CET
ADOCIA
Adocia annonce le bilan semestriel du contrat de liquidité Adocia conclu avec la société Kepler Capital Markets
20103010 Biotechnology
Other subject
13 Jan 2022
18:00 CET
ADOCIA
Adocia Announces Half Year Report on Adocia’s Liquidity Agreement With Kepler Capital Markets
20103010 Biotechnology
Other subject
11 Jan 2022
18:00 CET
ADOCIA
Number of shares and voting rights of ADOCIA as of December 31st, 2021
20103010 Biotechnology
Other subject
11 Jan 2022
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 décembre 2021
20103010 Biotechnology
Other subject
06 Jan 2022
18:00 CET
ADOCIA
Adocia Announces Its Financial Calendar for 2022
20103010 Biotechnology
Other subject
06 Jan 2022
18:00 CET
ADOCIA
Adocia annonce son calendrier financier pour l’année 2022
20103010 Biotechnology
Other subject
20 Dec 2021
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of November 30th, 2021
20103010 Biotechnology
Other subject
20 Dec 2021
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 novembre 2021
20103010 Biotechnology
Other subject
15 Dec 2021
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 novembre 2021
20103010 Biotechnology
Other subject
15 Dec 2021
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of November 30th, 2021
20103010 Biotechnology
Other subject
13 Dec 2021
18:00 CET
ADOCIA
Adocia Files Patent for Technology to Enable Oral Drug Delivery of Peptides
20103010 Biotechnology
New
13 Dec 2021
18:00 CET
ADOCIA
Adocia annonce le dépôt d’un brevet sur une technologie de délivrance orale de peptides
20103010 Biotechnology
New
19 Nov 2021
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 octobre 2021
20103010 Biotechnology
Other subject
19 Nov 2021
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of October 31st, 2021
20103010 Biotechnology
Other subject
26 Oct 2021
20:30 CEST
ADOCIA
ADOCIA annonce ses résultats financiers du 3ème trimestre et un financement de 7 millions d’euros
20103010 Biotechnology
Other subject
26 Oct 2021
20:30 CEST
ADOCIA
Adocia Announces 2021 Third Quarter Financial Results and a Financing of €7 Million
20103010 Biotechnology
Other subject
14 Oct 2021
07:30 CEST
ADOCIA
Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China
20103010 Biotechnology
Other subject
14 Oct 2021
07:30 CEST
ADOCIA
Adocia annonce que son partenaire Tonghua Dongbao a reçu l'autorisation de commencer le programme de Phase 3 de l'insuline ultra-rapide BioChaperone® Lispro pour le traitement des diabètes de type 1 et 2 en Chine
20103010 Biotechnology
Other subject
12 Oct 2021
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of September 30th, 2021
20103010 Biotechnology
Other subject
12 Oct 2021
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 septembre 2021
20103010 Biotechnology
Other subject
21 Sep 2021
18:00 CEST
ADOCIA
Adocia Announces Oral Presentation Reviewing M1Pram (ADO09) at the 57th Annual Meeting of the European Association for the Study of Diabetes (EASD)
20103010 Biotechnology
Other subject
21 Sep 2021
18:00 CEST
ADOCIA
Adocia annonce une présentation orale de M1Pram (ADO09) à l’occasion du 57ème Congrès Annuel de l’Association Européenne pour l’Etude du Diabète (EASD)
20103010 Biotechnology
Other subject
13 Sep 2021
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of August 31st, 2021
20103010 Biotechnology
Other subject
13 Sep 2021
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 Août 2021
20103010 Biotechnology
Other subject
10 Sep 2021
07:30 CEST
ADOCIA
Adocia to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
20103010 Biotechnology
Meetings / events
10 Sep 2021
07:30 CEST
ADOCIA
Adocia fera une présentation lors de l’évènement H.C. Wainwright Global Investment Conference
20103010 Biotechnology
Meetings / events
07 Sep 2021
18:00 CEST
ADOCIA
Adocia Announces First Half 2021 Financial Results and Provides an Update on Activities
20103010 Biotechnology
Other subject
07 Sep 2021
18:00 CEST
ADOCIA
Adocia annonce ses résultats financiers pour le premier semestre 2021 et fait le point sur ses activités
20103010 Biotechnology
Other subject
23 Aug 2021
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 Juillet 2021
20103010 Biotechnology
Other subject
23 Aug 2021
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of July 31st, 2021
20103010 Biotechnology
Other subject
29 Jul 2021
18:00 CEST
ADOCIA
Adocia annonce le bilan semestriel du contrat de liquidité Adocia conclu avec la société Kepler Capital Markets
20103010 Biotechnology
Other subject
29 Jul 2021
18:00 CEST
ADOCIA
Adocia Announces Half Year Report on Adocia’s Liquidity Agreement With Kepler Capital Markets
20103010 Biotechnology
Other subject
22 Jul 2021
18:31 CEST
ADOCIA
ADOCIA annonce ses résultats financiers du 2ème trimestre 2021
20103010 Biotechnology
Other subject
22 Jul 2021
18:31 CEST
ADOCIA
ADOCIA Announces Second Quarter 2021 Financial Results
20103010 Biotechnology
Other subject
15 Jul 2021
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of June 30th, 2021
20103010 Biotechnology
Other subject
15 Jul 2021
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 Juin 2021
20103010 Biotechnology
Other subject
29 Jun 2021
18:00 CEST
ADOCIA
Adocia Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes
20103010 Biotechnology
Other subject
29 Jun 2021
18:00 CEST
ADOCIA
Adocia initie une étude de Phase 1 chez le patient diabétique de type 1 avec BC LisPram administré en pompe
20103010 Biotechnology
Other subject
15 Jun 2021
07:30 CEST
ADOCIA
ADOCIA annonce une présentation des résultats cliniques de M1Pram à l’occasion des 81èmes Sessions Scientifiques de l’American Diabetes Association®
20103010 Biotechnology
Other subject
15 Jun 2021
07:30 CEST
ADOCIA
ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81st Scientific Sessions
20103010 Biotechnology
Other subject
10 Jun 2021
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 Mai 2021
20103010 Biotechnology
Other subject
10 Jun 2021
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of May 31st, 2021
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
3
4
5
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva